What is the primary goal of postpartum anticoagulation for women with a history of VTE and no thrombophilia?

The primary goal of postpartum anticoagulation for women with a history of venous thromboembolism (VTE) and no underlying thrombophilia is to provide prophylaxis. After delivery, women who have a history of VTE are at increased risk for recurrence, particularly in the immediate postpartum period due to changes in hemostatic factors and venous return. Anticoagulant prophylaxis is crucial in significantly reducing the risk of future thrombotic events.

In this context, prophylaxis involves administering low-molecular-weight heparin or other anticoagulants at a preventive dosage rather than therapeutic doses aimed at treating existing clots. Monitoring is also an important aspect of managing anticoagulation therapy but is secondary to the aim of providing preventive care. The option stating that no treatment is necessary does not consider the increased risk of VTE in these patients. A therapeutic treatment approach may not be warranted unless there are further complications or existing clots, making prophylaxis the most appropriate goal in uncomplicated cases.